UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 12, pp. 1111 - 1120
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Disability Evaluation | Analgesics - therapeutic use | Pregabalin - administration & dosage | Pregabalin - adverse effects | Back Pain - classification | Double-Blind Method | Pregabalin - therapeutic use | Humans | Middle Aged | Sciatica - classification | Dizziness - chemically induced | Analgesics - administration & dosage | Male | Sciatica - drug therapy | Treatment Failure | Quality of Life | Adult | Female | Aged | Pain Measurement | Analgesics - adverse effects | Complications and side effects | Treatment outcome | Patient outcomes | Placebos | Dosage and administration | Pregabalin | Drug therapy | Comparative analysis | Sciatica | Pain | Neurons | Pain management | Clinical trials | Neuropathy | Patients | Leg | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 2008, Volume 31, Issue 2, pp. S255 - 261
Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Aldehyde Reductase - antagonists & inhibitors | Diabetic Neuropathies - prevention & control | Humans | Polyneuropathies - epidemiology | Polyneuropathies - prevention & control | Analgesics, Opioid - therapeutic use | Polyneuropathies - drug therapy | Clinical Trials as Topic | Diabetic Neuropathies - drug therapy | Imidazolidines - therapeutic use | Polyneuropathies - physiopathology | Enzyme Inhibitors - therapeutic use | Incidence | Inositol - blood | Diabetic Neuropathies - epidemiology | Sodium Channel Blockers - therapeutic use | Sodium-Potassium-Exchanging ATPase - blood | Diabetic Neuropathies - physiopathology | Medical research | Anticonvulsants | Care and treatment | Pain | Medicine, Experimental | Diabetes | Health aspects | Risk factors | Studies | Side effects | Hospitals | Mortality | Diabetic neuropathy | Clinical medicine | Drug therapy | Foot diseases | Drug use | Quality of life | Fibers | Index Medicus
Journal Article
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 5, pp. 417 - 422
NMDA receptor antagonists, therapeutic use | GABA receptor agonists, therapeutic use | Neuropathic pain, treatment | Local anaesthetics, therapeutic use | Antiepileptic drugs, therapeutic use | Antidepressants, therapeutic use | Diabetic nephropathies, treatment | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Antidepressive Agents - therapeutic use | Animals | Neuralgia, Postherpetic - complications | Humans | Anticonvulsants - therapeutic use | Analgesics, Opioid - therapeutic use | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Diabetic Neuropathies - complications | Topiramate | Gabapentin | Desipramine | Capsaicin | Oxycodone | Clinical trials | Serotonin uptake inhibitors | Nervous system | Diabetic neuropathy | Infections | Dextromethorphan | Neuropathy | Antiepileptic agents | Peripheral neuropathy | Oxcarbazepine | Imipramine | Pain | Analgesics | Antidepressants | Tramadol | Opioids | Drug therapy | Drug dosages | Amitriptyline | Narcotics | Diabetes mellitus | Duloxetine | Valproic acid | Carbamazepine | Quality of life | Studies | Norepinephrine | Diabetes | Neuralgia | Lidocaine | Phenytoin | Lamotrigine
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2019, Volume 2019, Issue 5, pp. CD007076 - CD007076
Acute Disease | Pharmacological treatment | Pregabalin | Management | Pain & anaesthesia | 2019 3. Chronic pain | Diabetic Neuropathies | Randomized Controlled Trials as Topic | Dizziness | Chronic non‐cancer pain | Pain | 2019 3.1 Neuropathic pain | Orthopaedics & trauma | Analgesics | Neuralgia, Postherpetic | Neuralgia | Pharmacological therapies | Acute pain | Medicine General & Introductory Medical Sciences | Drugs by category/name | Chronic Disease | Sleepiness | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Analgesics - therapeutic use | Pregabalin - administration & dosage | Pregabalin - adverse effects | Pregabalin - therapeutic use | Humans | Dizziness - chemically induced | Analgesics - administration & dosage | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Neuralgia - drug therapy | Pain - drug therapy | Adult | Analgesics - adverse effects | Index Medicus
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 10/2018, Volume 550, Issue 1-2, pp. 160 - 169
Dose proportionality | Non-effervescent | Pregabalin | Gastroretentive drug delivery system | Swelling | Floating | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pregabalin - administration & dosage | Pregabalin - pharmacokinetics | Hypromellose Derivatives - chemistry | Drug Compounding - methods | Analgesics - administration & dosage | Male | Analgesics - pharmacokinetics | Drug Delivery Systems | Povidone - chemistry | Animals | Analgesics - chemistry | Dogs | Pregabalin - chemistry | Drug Liberation | Tablets - chemistry | Drugs | Drug delivery systems | Methylcellulose | Analysis | Vehicles
Journal Article
British journal of anaesthesia : BJA, ISSN 0007-0912, 10/2017, Volume 119, Issue 4, pp. 775 - 791
postoperative | pain | antipyretics | pregabalin | analgesics | gamma-aminobutyric acid | Lyrica | Life Sciences & Biomedicine | Anesthesiology | Science & Technology | Analgesics - therapeutic use | Pregabalin - adverse effects | Acute Disease | Pain, Postoperative - drug therapy | Pregabalin - therapeutic use | Humans | Treatment Outcome | Analgesics - adverse effects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 6, pp. 550 - 556
Life Sciences & Biomedicine | Oncology | Science & Technology | Analgesics - therapeutic use | Bone and Bones | Pregabalin - adverse effects | Double-Blind Method | Pregabalin - therapeutic use | Humans | Middle Aged | Pain Management - methods | Analgesics, Opioid - therapeutic use | Male | Affect | Chemoradiotherapy | Activities of Daily Living | Neoplasms - complications | Breakthrough Pain - therapy | Quality of Life | Adult | Female | Aged | Pain Measurement | Breakthrough Pain - etiology | Analgesics - adverse effects | Palliative Care - methods | Index Medicus | Pedi23 | To23 | Psc2 | ORIGINAL REPORTS | Radn
Journal Article